— Know what they know.
Not Investment Advice

EQ NASDAQ

Equillium, Inc.
1W: -1.4% 1M: -19.1% 3M: -40.4% YTD: -11.1% 1Y: -3.5% 3Y: +130.5% 5Y: -76.2%
$1.36
+0.11 (+8.80%)
 
Weekly Expected Move ±13.3%
$1 $1 $1 $1 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $86.2M mcap · 37M float · 1.81% daily turnover · Short 51% of daily vol
Credit Risk of going bust: higher than 56% of companies Debt: 0.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down 99.8%), Equillium, Inc. would be worth roughly what it owes.
Total debt $584K against a stock market value of $86.2M.
Distance to default 4.53 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $498K (short-term plus half of long-term), stock volatility 103.7%; Altman Z'' 13.72. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$32M +24.5% ▲
5Y CAGR: -17.9%
Total Liabilities
$3M -49.7% ▼
5Y CAGR: -26.7%
Shareholders Equity
$29M +50.0% ▲
5Y CAGR: -16.4%
Cash & Investments
$30M +34.1% ▲
5Y CAGR: -18.1%
Total Debt
$719K +87.2% ▲
5Y CAGR: -40.9%
Net Debt
-$30M -67.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$50M$59M$23M$18M$30M
Short-Term Investments$30M$12M$18M$4M$0
Cash & ST Investments$81M$71M$41M$23M$30M
Net Receivables$0$4M$6M$1M$108K
Inventory$0$0$0$0$0
Other Current Assets$0$8K$235K$429K-$547K
Total Current Assets$83M$77M$49M$25M$30M
Property, Plant & Equip.$2M$2M$1M$626K$658K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$153K$104K$70K$0$0
Total Non-Current Assets$2M$2M$1M$626K$658K
Total Assets$85M$78M$51M$26M$32M
— Liabilities —
Accounts Payable$1M$4M$5M$3M$755K
Short-Term Debt$1M$6M$0$197K$363K
Deferred Revenue$0$15M$16M$0$0
Other Current Liabilities$3M$0$4M$3M$2M
Total Current Liabilities$9M$32M$28M$6M$3M
Long-Term Debt$9M$3M$0$0$356K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$10M$14M$384K$187K$356K
Total Liabilities$19M$46M$28M$7M$3M
— Equity —
Common Stock$2K$3K$3K$3K$5K
Retained Earnings-$110M-$172M-$186M-$194M-$216M
Accumulated OCI-$138K$76K$140K$781K$363K
Total Stockholders Equity$67M$32M$23M$19M$29M
Total Liabilities & Equity$85M$78M$51M$26M$32M
— Key Metrics —
Total Debt$12M$10M$824K$384K$719K
Net Debt-$39M-$49M-$22M-$18M-$30M
Total Investments$30M$12M$18M$4M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms